Health
Pfizer says Covid pill 'Paxlovid' 89% effective against severe disease
The results from the clinical trial are so good that Pfizer will stop recruiting new people for the trial, the company said
Covid booster dose effective in reducing severe disease outcomes: Lancet study
Individuals were assigned to each group dynamically based on their changing vaccination status
Suicide rate up in 2020 in India, Maharashtra tops the list with near 20k
The overall male to female ratio of suicide victims was 70.9 to 29.1, the report stated
Cheap antidepressant shows promise treating early COVID-19
Some experts predict various treatments eventually will be used in combination to fight the coronavirus
Long COVID may not be as fatal as acute COVID-19 but can worsen existing ailments
About half of people with long-COVID reported an improvement in their symptoms after getting the vaccine
Children who spent more time in nature during lockdown fared best: Study
Children from less affluent backgrounds are likely to have found COVID-19 lockdowns more challenging to their mental health
Vaccines prevent severe Covid, even from Delta: study
The researchers compared the outcomes of 11 million vaccinated people with 11 million unvaccinated subjects
Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing
Smoking may increase risk of COVID-19 severity, death, study finds
The latest study is first of its kind to pool observational and genetic data on smoking and COVID-19
Covid virus expected to continue to transmit for a very long time: WHO
Populations where more people were previously infected and where vaccination coverage is high are expected to be less impacted by the virus